All Updates

WASHINGTON, D.C. July 2, 2014 A new report released today by the White House Council of Economic Advisors finds that millions of uninsured Americans continue to go without health coverage because several states have chosen not to increase access to Medicaid. A statement from Christopher Hansen, president of the American

WASHINGTON, D.C. June 24, 2014 The Centers for Disease Control and Prevention (CDC) released new advertisements today as part of its ongoing Tips from Former Smokers national campaign. The following is a statement from John R. Seffrin, CEO of the American Cancer Society Cancer Action Network (ACS CAN): The ads

Washington, DC More than 250 childhood cancer patients, survivors and their families will be on Capitol Hill on Tuesday, June 24 to ask Congress to continue to support initiatives that can improve research, treatment and outcomes for children with cancer. The third annual Childhood Cancer Action Day event,

WASHINGTON, DC On the fifth anniversary of the landmark 2009 law granting the Food and Drug Administration (FDA) authority over tobacco products, 10 leading public health and medical organizations today commended the FDA for the steps it has taken to reduce tobacco use and called on the FDA and the

WASHINGTON, D.C. June 12, 2014 The Centers for Disease Control and Prevention (CDC) today released results from the Youth Risk Behavior Surveillance (YRBS) survey showing youth cigarette use has declined to 15.7 percent, a historic low. Following is a statement the American Cancer Society Cancer Action Network (ACS CAN): Historically

WASHINGTON, DC – U.S. District Judge Gladys Kessler on Monday issued a final order detailing how major U.S. cigarette manufacturers must publish “corrective statements” and finally tell the American people the truth about their deadly and addictive products. Judge Kessler first ordered the corrective statements in 2006 when she

Following is a statement from the American Cancer Society Cancer Action Network (ACS CAN) commending the Food and Drug Administration (FDA) for finalizing its order to reclassify indoor tanning devices from a class I to a class II medical device, imposing greater control over their manufacture and distribution.